Stay updated with breaking news from Wize Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The first Israeli biotech company, where he served as Director of R&D from 1980 to 1987. During his managerial career Dr. Havron was directly involved in the multi-disciplinary development of many... | June 8, 2023
Vertua Limited (NSX:VER) purses unique investment opportunities.
Share this article Share this article ResearchAndMarkets.com's offering. This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides insights across retinal diseases, viral and non-viral vector platforms for gene therapies, allogeneic cell therapy, bone repair, gluten antigen-specific drug therapy for Celiac disease, plant-based anti-cancer agents, and food colors. Further, PCR-free whole genome sequencing, oral protein-drug delivery technology for insulin, and cryo transmission electron microscope for viral protein analysis are discussed. The Life Science...
Pharma Leader Series: Top 50 Ophthalmic Drug Manufacturers Market Report 2021-2031 In-depth Analysis of Top 50 Ophthalmic Drug Manufacturers: Capabilities, Results, Competition and Sales Potentials Visiongain has published a new Pharma Leader Series report on Top 50 Ophthalmic Drug Manufacturers Market Report 2021-2031. May 05, 2021 10:45 ET | Source: ReportLinker ReportLinker Lyon, FRANCE New York, May 05, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Pharma Leader Series: Top 50 Ophthalmic Drug Manufacturers Mar...
Wize Pharma set for switch to Bitcoin mining Wize Pharma has spun off its ophthalmology drug development activities, and will begin to mine digital currencies in another month through Cosmos. Wize Pharma (OTCQB: WIZP), from Hod Hasharon, has reported that it has met all the preconditions for implementing the offer to purchase the shares of Australian bitcoin miner Cosmos Capital Ltd. Wize Pharma expects to complete the purchase of the shares by March 9, 2021. One of the conditions was that the level of response should be a minimum of 90% of Cosmos shareholders, and as of yesterday a response ...